Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
492.51
+5.29 (1.09%)
At close: May 29, 2026, 4:00 PM EDT
492.90
+0.39 (0.08%)
After-hours: May 29, 2026, 7:57 PM EDT
Thermo Fisher Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 45,197 | 44,556 | 42,879 | 42,857 | 44,915 | 39,211 | |
Revenue Growth (YoY) | 5.36% | 3.91% | 0.05% | -4.58% | 14.55% | 21.70% |
Cost of Revenue | 7,143 | 26,318 | 25,177 | 25,757 | 25,944 | 19,573 |
Gross Profit | 38,054 | 18,238 | 17,702 | 17,100 | 18,971 | 19,638 |
Selling, General & Admin | 8,460 | 8,732 | 8,595 | 8,445 | 8,993 | 8,007 |
Depreciation & Amortization Expenses | 436 | - | - | - | - | - |
Research & Development | 1,390 | 1,397 | 1,390 | 1,337 | 1,471 | 1,406 |
Other Operating Expenses | 312 | 362 | 379 | 459 | 114 | 197 |
Total Operating Expenses | 10,598 | 10,491 | 10,364 | 10,241 | 10,578 | 9,610 |
Operating Income | 7,893 | 7,746 | 7,337 | 6,859 | 8,393 | 10,028 |
Interest Income | 1,022 | 993 | 1,078 | 879 | 272 | 43 |
Interest Expense | -1,470 | -1,419 | -1,390 | -1,375 | -726 | -536 |
Other Non-Operating Income (Expense) | -24 | -12 | 12 | -65 | -104 | -694 |
Total Non-Operating Income (Expense) | -472 | -438 | -300 | -561 | -558 | -1,187 |
Pretax Income | 7,422 | 7,308 | 7,037 | 6,298 | 7,835 | 8,841 |
Provision for Income Taxes | 522 | 547 | 657 | 284 | 703 | 1,109 |
Net Income | 6,848 | 6,704 | 6,335 | 5,995 | 6,950 | 7,725 |
Minority Interest in Earnings | 54 | 58 | 45 | 19 | 182 | 7 |
Net Income to Common | 6,848 | 6,704 | 6,335 | 5,995 | 6,950 | 7,725 |
Net Income Growth | 5.11% | 5.83% | 5.67% | -13.74% | -10.03% | 21.18% |
Shares Outstanding (Basic) | 376 | 377 | 382 | 386 | 392 | 394 |
Shares Outstanding (Diluted) | 377 | 378 | 383 | 388 | 394 | 397 |
Shares Change (YoY) | -1.50% | -1.31% | -1.29% | -1.52% | -0.76% | -0.50% |
EPS (Basic) | 18.22 | 17.77 | 16.58 | 15.52 | 17.75 | 19.62 |
EPS (Diluted) | 18.19 | 17.74 | 16.53 | 15.45 | 17.63 | 19.46 |
EPS Growth | 6.69% | 7.32% | 6.99% | -12.37% | -9.40% | 21.93% |
Shares Outstanding | 371.62 | 376.22 | 380.77 | 386.65 | 389 | 394.28 |
Free Cash Flow | 6,748 | 6,293 | 7,267 | 6,927 | 6,911 | 6,789 |
Free Cash Flow Growth | 7.23% | -13.40% | 4.91% | 0.23% | 1.80% | -0.38% |
Free Cash Flow Per Share | 17.92 | 16.65 | 18.97 | 17.85 | 17.54 | 17.10 |
Dividends Per Share | 1.760 | 1.720 | 1.560 | 1.400 | 1.200 | 1.040 |
Dividend Growth | 2.33% | 10.26% | 11.43% | 16.67% | 15.38% | 18.18% |
Gross Margin | 84.20% | 40.93% | 41.28% | 39.90% | 42.24% | 50.08% |
Operating Margin | 17.46% | 17.38% | 17.11% | 16.00% | 18.69% | 25.57% |
Profit Margin | 15.27% | 15.17% | 14.88% | 14.03% | 15.88% | 19.72% |
FCF Margin | 14.93% | 14.12% | 16.95% | 16.16% | 15.39% | 17.31% |
EBITDA | 10,704 | 10,526 | 10,445 | 10,265 | 11,774 | 12,620 |
EBITDA Margin | 23.68% | 23.62% | 24.36% | 23.95% | 26.21% | 32.18% |
EBIT | 7,893 | 7,746 | 7,337 | 6,859 | 8,393 | 10,028 |
EBIT Margin | 17.46% | 17.38% | 17.11% | 16.00% | 18.69% | 25.57% |
Effective Tax Rate | 7.03% | 7.48% | 9.34% | 4.51% | 8.97% | 12.54% |